Lincoln Pharmaceuticals consolidated net profit rises 26.07% in the September 2019 quarter
Sales rise 9.83% to Rs 112.69 crore
Net profit of Lincoln Pharmaceuticals rose 26.07% to Rs 18.91 crore in the quarter ended September 2019 as against Rs 15.00 crore during the previous quarter ended September 2018. Sales rose 9.83% to Rs 112.69 crore in the quarter ended September 2019 as against Rs 102.60 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales112.69102.60 10 OPM %21.9018.61 -PBDT26.6221.76 22 PBT24.8520.26 23 NP18.9115.00 26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content